Get the Stockscreener App
50.82
3.97%
-2.10
Bruker Corp stock is traded at $50.82, with a volume of 1.99M.
It is down -3.97% in the last 24 hours and down -15.40% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
See More
Previous Close:
$52.92
Open:
$52.64
24h Volume:
1.99M
Relative Volume:
1.30
Market Cap:
$7.70B
Revenue:
$3.24B
Net Income/Loss:
$304.90M
P/E Ratio:
24.43
EPS:
2.08
Net Cash Flow:
$156.70M
1W Performance:
+1.56%
1M Performance:
-15.40%
6M Performance:
-21.88%
1Y Performance:
-37.96%
1-Day Range:
$50.44
$52.92
1-Week Range:
$49.29
$54.48
52-Week Range:
$48.07
$94.86
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
50.82 | 7.70B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker Corporation appoints new board member - Investing.com
Can This New 18,000-Gene Spatial Biology Platform Transform Cancer Research? - StockTitan
Steady Returns Continue: Bruker's Latest Dividend Decision Signals Financial Health - StockTitan
Frank Laukien Buys Handful Of Shares In Bruker - Yahoo Canada Finance
Four Major Healthcare Conferences: Where Bruker Will Share Its 2025 Vision - StockTitan
Bruker corp CEO Frank Laukien buys $1.02m in company stock By Investing.com - Investing.com South Africa
Bruker corp CEO Frank Laukien buys $1.02m in company stock - Investing.com Nigeria
Equities Analysts Set Expectations for Bruker Q1 Earnings - MarketBeat
Bruker (NASDAQ:BRKR) Issues FY 2025 Earnings Guidance - MarketBeat
Bruker Corporation (NASDAQ:BRKR) Q4 2024 Earnings Call Transcript - Insider Monkey
Bruker Co. (NASDAQ:BRKR) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Bruker Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
FY2025 Earnings Estimate for Bruker Issued By Zacks Research - MarketBeat
Bruker (NASDAQ:BRKR) Announces Quarterly Earnings Results - MarketBeat
Glycomics Market Size Expected to Reach USD 8.66 Bn by 2034 - GlobeNewswire Inc.
Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls - Yahoo Finance
Bruker Corp (BRKR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Outlook ... - Yahoo Finance
Bruker Corp (BRKR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Outlook ... By GuruFocus - Investing.com Canada
Bruker (NASDAQ:BRKR) Shares Gap Down Following Analyst Downgrade - MarketBeat
Bruker: Q4 Earnings Snapshot - The Washington Post
Bruker Corp Q4 2024 Earnings: EPS of $0.76 Beats Estimates, Reve - GuruFocus.com
Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say - MSN
Bruker earnings beat by $0.02, revenue topped estimates - Investing.com
Earnings call transcript: Bruker Q4 2024 beats EPS forecast, stock dips - Investing.com
Bruker (BRKR) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Bruker’s (NASDAQ:BRKR) Q4 Sales Top Estimates But Full-Year Sales Guidance Misses Expectations - Yahoo Finance
Bruker reports Q4 earnings beat, issues in-line 2025 guidance By Investing.com - Investing.com South Africa
Bruker reports Q4 earnings beat, issues in-line 2025 guidance - Investing.com
Bruker Corporation Reports Q4 and FY 2024 Financial Results - TradingView
Bruker Earnings Smash Expectations: Q4 Revenue Hits Record $979.6M, Charts Ambitious Growth Path - StockTitan
Bruker Earnings: What To Look For From BRKR - Yahoo Canada Finance
Bruker (NASDAQ:BRKR) Given New $65.00 Price Target at Barclays - Defense World
Bruker Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) - Benzinga
Bruker Spatial Biology promotes Bhaswar Maity - Medical Buyer
Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast - Yahoo Finance
Bruker Q4 2024 Earnings Date Confirmed: Here's When BRKR Reports Critical Year-End Results - StockTitan
Investing in Bruker Corp (BRKR) might be a great opportunity, but the stock is a bit overvalued - US Post News
Bruker Co. (NASDAQ:BRKR) Shares Sold by SG Americas Securities LLC - Defense World
10x, Harvard settle genomics patent dispute with Vizgen during trial - Reuters
Bruker (BRKR) to Report Q4 Results: Wall Street Expects Earnings Growth - MSN
Bruker (BRKR) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
SteelPeak Wealth LLC Has $214,000 Stock Holdings in Bruker Co. (NASDAQ:BRKR) - MarketBeat
Merit Financial Group LLC Makes New Investment in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker (BRKR) Stock Price, News & Analysis - MarketBeat
CALID Arm Growth to Support Bruker Shares Amid Macro Issues - Yahoo Finance
Spatial Proteomics Market Report and Competitive Landscape 2025-2030, with 10X Genomics, Bruker, Fluidigm, Akoya Biosciences, PerkinElmer, Biotechne, S2 Genomics, Seven Bridges Genomics & More - Yahoo Finance
Park Avenue Securities LLC Has $433,000 Stake in Bruker Co. (NASDAQ:BRKR) - Defense World
Infrared Imaging Microscope | Bruker Optics Inc. | Products - Photonics.com
Leerink Partnrs Issues Positive Estimate for Bruker Earnings - Defense World
Bruker Co. (NASDAQ:BRKR) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Bruker Co. (NASDAQ:BRKR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bruker Corp Stock (BRKR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
1.16%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):